본문 바로가기

Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q1Scopus Q1KCI Q1
피인용
Web of Science 3Scopus 3KCI 0
FWCI (Scopus)
0.56
JCR IF
JCR 2022 3
ISSN
1976-8710

저자

  1. Kwon, Seong Keun제1저자Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea
  2. Park, Sung JoonChung Ang Univ, Gwangmyeong Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Gwangmyeong, South Korea
  3. Chung, Eun-JaeSeoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea
  4. Sohn, Jin-HoKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea
  5. Sun, Dong-IlCatholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Africa
  6. 이병주Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Busan, South Korea
  7. Park, Il-SeokHallym Univ, Dongtan Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Suwon, South Korea
  8. Cho, Jae-GuKorea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Guro Hosp, Seoul, South Korea
  9. Park, Young Hak교신저자Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 10 63 Yuksam Ro, Seoul, South Korea

초록

Objectives. This study aimed to assess predictors of the response to varying durations of proton pump inhibitor (PPI) use and lifestyle modification treatment for laryngopharyngeal reflux disease (LPRD). Methods. Between October 2014 and June 2016, a prospective, multicenter, open-label, single-cohort, intention-to-treat, observational study was conducted at eight referral hospitals across the Republic of Korea to examine predictors of early and late response to treatment in adult patients (age & GE;19 years) with LPRD. Participants underwent standard treatment (PPI [Esomezol] and lifestyle modification) for 3 months. Response to treatment was defined as greater than 50% improvement in reflux symptom index score. The primary outcome was potential predictors of treatment re-sponse at 1 and 3 months. The secondary outcome was potential predictors distinguishing early from late responders. Results. In total, 394 patients were enrolled. Improved sleep habits was a positive predictor (odds ratio [OR], 1.785; 95% confidence interval [CI], 1.06-3.007; P=0.029), while initial alcohol consumption (OR, 0.587; 95% CI, 0.355-0.969; P= 0.037) and past medication history (OR, 0.438; 95% CI, 0.215-0.891; P= 0.005) were negative predictors of re-sponse after 1 month of treatment. High pre-reflux finding score was a positive predictor (OR, 1.187; 95% CI, 1.049- 1.344; P= 0.007), while male sex (OR, 0.516; 95% CI, 0.269-0.987; P= 0.046), higher depression score (OR, 0.867; 95% CI, 0.784-0.958; P= 0.005), and past thyroid hormone medication history (OR, 0.161; 95% CI, 0.033-0.788; P=0.024) were negative predictors of response after 3 months of treatment. Past medication history (OR, 0.438; 95% CI, 0.215-0.891; P=0.023) was the only negative predictor for early responders compared to late responders. Conclusion. Adult patients with LPRD and a history of prior medication use may require longer treatment durations to achieve a therapeutic response. Future research should explore the incorporation of diverse treatment approaches to improve treatment outcomes for patients exhibiting negative prognostic indicators.

키워드

Laryngopharyngeal RefluxProton Pump InhibitorsLife Style ModificationPredictive FactorPatient CompliancePatient Medi-cal HistoryMedication HistoryPUMP INHIBITOR THERAPYRABEPRAZOLEPREVALENCEMANAGEMENTSYMPTOMSTRIAL

식별자

Scopus EID
2-s2.0-85169443879
WoS UID
001046175000001
KCI
ART002986871